Skip to main content

Table 1 Demographic and clinical characteristics of 202 subjects with Wilson disease included in the study population

From: Social and demographic characteristics of a Polish cohort with Wilson disease and the impact of treatment persistence

Variable n = 202

Values

Male:female ratio, n (%)

93 (46):109 (54)

Age, mean ± SD (years)

36.4 ± 9.9

Age at diagnosis, mean ± SD (years)

25.8 ± 9.8

Latency period,a mean ± SD (months)

14.2 ± 12.0

Length of treatment, mean ± SD (years)

11.0 ± 3.2

Predominant clinical form, n (%)

 - Pre-symptomatic

22 (10.9)

 - Hepatic

73 (36.1)

 - Neurological

107 (53.0)

Drug compliance (persistence),b n (%)

 Yes

139c (72.4)

 No

53 (27.6)

  1. SD standard deviation
  2. aThe period since first clinical symptoms
  3. bPatients were considered non-persistent if they had at least one break of ≥3 months or more than 2 breaks lasting for ≥2 months within the last 3 years of treatment
  4. c10 patients received liver transplants and stopped taking medication for Wilson disease